<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cramer P</submitter><funding>Deutsche Forschungsgemeinschaft (DFG)</funding><funding>University of Rijeka</funding><funding>croatian science foundation</funding><pagination>795-823</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12905349</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(2)</volume><pubmed_abstract>Virus infections elicit long-term IgG antibody and memory responses. Human cytomegalovirus (HCMV) is widespread in humans and disseminates despite the presence of virus-specific antibodies. Here, we report that the HCMV Fcγ-binding glycoprotein 34 modulates humoral immunity by binding to IgG⁺ memory B cells. gp34-B cell receptor (BCR) interaction initiates activation of the PDK1/AKT/mTOR/S6 pathway and BCR internalization in a SYK-independent manner. Prolonged stimulation also induces B-cell activation via upregulation of CD69 and CD86. In a T-cell-dependent response, however, interaction with gp34 blocks B-cell proliferation, differentiation into plasmablasts, and soluble IgG production, while stimulating TNF-α secretion. Through gp34 stimulation on IgG⁺ B cells, neighboring IgM⁺ and IgA⁺</pubmed_abstract><journal>EMBO molecular medicine</journal><pubmed_title>A viral glycoprotein targets IgG&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; memory B cells to mediate humoral immune evasion.</pubmed_title><pmcid>PMC12905349</pmcid><funding_grant_id>SFP1160</funding_grant_id><funding_grant_id>HE2526/9-2</funding_grant_id><funding_grant_id>468499998</funding_grant_id><funding_grant_id>KK.01.1.1.01.0006</funding_grant_id><funding_grant_id>IP-2020-02-6617</funding_grant_id><funding_grant_id>uniri-biomed-18-233</funding_grant_id><funding_grant_id>JO1634/1-1</funding_grant_id><pubmed_authors>Kolb P</pubmed_authors><pubmed_authors>Falcone V</pubmed_authors><pubmed_authors>Rizzi M</pubmed_authors><pubmed_authors>Lenac Rovis T</pubmed_authors><pubmed_authors>Janowska I</pubmed_authors><pubmed_authors>Jonjic S</pubmed_authors><pubmed_authors>Neys SFH</pubmed_authors><pubmed_authors>Fiedler M</pubmed_authors><pubmed_authors>Kohl AK</pubmed_authors><pubmed_authors>Staniek J</pubmed_authors><pubmed_authors>Plachter B</pubmed_authors><pubmed_authors>Cramer P</pubmed_authors><pubmed_authors>Huber M</pubmed_authors><pubmed_authors>Read C</pubmed_authors><pubmed_authors>Hoffmann K</pubmed_authors><pubmed_authors>Hadlova P</pubmed_authors><pubmed_authors>Reinhard H</pubmed_authors><pubmed_authors>von Einem J</pubmed_authors><pubmed_authors>Lorenzetti R</pubmed_authors><pubmed_authors>Hengel H</pubmed_authors></additional><is_claimable>false</is_claimable><name>A viral glycoprotein targets IgG&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; memory B cells to mediate humoral immune evasion.</name><description>Virus infections elicit long-term IgG antibody and memory responses. Human cytomegalovirus (HCMV) is widespread in humans and disseminates despite the presence of virus-specific antibodies. Here, we report that the HCMV Fcγ-binding glycoprotein 34 modulates humoral immunity by binding to IgG⁺ memory B cells. gp34-B cell receptor (BCR) interaction initiates activation of the PDK1/AKT/mTOR/S6 pathway and BCR internalization in a SYK-independent manner. Prolonged stimulation also induces B-cell activation via upregulation of CD69 and CD86. In a T-cell-dependent response, however, interaction with gp34 blocks B-cell proliferation, differentiation into plasmablasts, and soluble IgG production, while stimulating TNF-α secretion. Through gp34 stimulation on IgG⁺ B cells, neighboring IgM⁺ and IgA⁺</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-15T22:16:18.715Z</modification><creation>2026-07-09T10:18:58.439Z</creation></dates><accession>S-EPMC12905349</accession><cross_references><pubmed>41559372</pubmed><doi>10.1038/s44321-026-00372-1</doi></cross_references></HashMap>